Sean Cassidy, CEO of Lucem Health: Novel AI Solutions for Early Disease Detection
By Rob Dillard - Last Updated: May 11, 2023Lucem Health™ recently announced the availability of its new early disease detection solution, Lucem Health Reveal. Lucem Health Reveal uses artificial intelligence to leverage existing EHR data to identify patients who may be at a higher risk of serious or chronic disease, such as cancer, diabetes, stroke, or heart disease.
Advertisement
DocWire News spoke with Sean Cassidy, founding CEO of Lucem Health, to learn more about the Company, and how clinical AI assists in early detection of patients at high risk for chronic illnesses.
Advertisement
Related Posts
A study aimed to assess RIPK3 inhibition in acute glaucoma using AI.
A groundbreaking study has demonstrated that artificial intelligence can enhance breast cancer detection rates by almost 20%.
An AI-based tool demonstrated superior performance in the diagnosis of head and neck squamous cell carcinoma.
Dr. Ted Kung discusses the RESTORE Neuromuscular Interface System for patients with upper limb loss.
Alister Campbell, of Dotmatics, details how artificial intelligence is changing the drug discovery process.
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.